Ascorbic acid attenuates aspirin-induced gastric damage: Role of inducible nitric oxide synthase

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 5, 2006, Pages 125-136

  Konturek, Peter C ^a   Kania, J ^a   Hahn, E G ^a   Konturek, J W ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Elbe Clinic   (Germany)

Author keywords

Acetylsalicylic acid; Cyclooxygenase 2; Inducible nitric oxide synthase; Vitamin c

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ASCORBIC ACID; ASPIRIN PLUS C; CLARITHROMYCIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; PANTOPRAZOLE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MONOTHERAPY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH MUCOSA LESION; STOMACH PROTECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASCORBIC ACID; ASPIRIN; CELLS, CULTURED; CYCLOOXYGENASE 2; DRUG INTERACTIONS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER;

EID: 34147093105     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002; 162: 2197-2202.
2. Lanas A. Prevention and treatment of NSAID-induced gastroduodenal injury. Curr Treat Options Gastroenterol 2006; 9: 147-156.
3. Laine L. GI risk and risk factors of NSAIDs. J Cardiovasc Pharmacol 2006; 47 Suppl 1: S60-66.
4. Wallace JL. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. Scientific World Journal 2006; 6: 577-588.
5. Bombardier C: An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002; 89: 3D-9D.
6. Brzozowski T, Kwiecien, S, Konturek PC, et al. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species. Med Sci Monit 2001; 7: 592-599.
7. Konturek PC, Kania, J, Gessner U, Konturek SJ, Hahn EG, Konturek JW. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy. Eur J Pharmacol 2004; 506: 169-177.
8. Becker JC, Grosser N, Boknik P, Schroder H, Domschke W, Pohle T. Gastroprotection by vitamin C - a heme oxygenase-1-dependent mechanism? Biochem Biophys Res Commun 2003; 312: 507-512.
9. Aburaya M, Tanaka KI, Hoshino T, et al. Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs. J Biol Chem 2006; 31 (epub ahead of print).
10. Lamarque D, Whittle BJ. Involvement of peroxynitrite in the lipid peroxidation induced by nitric oxide in rat gastric mucosa. Eur J Pharmacol 1996; 313: R5-7.
11. Konturek PC, Kania J, Burnat G, Hahn EG, Konturek SJ. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J Physiol Pharmacol 2005; 56: Suppl 5: 57-73.
12. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL. Aspirin causes rapid upregulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997; 11: 1101-1108.